Lucas P A, Brown R C, Bloodworth L, Woodhead J S
Proc Eur Dial Transplant Assoc. 1983;20:213-9.
Vitamin D3 metabolites and iPTH were measured in 26 patients at various times after renal transplantation. Hypercalcaemia (serum Ca greater than 2.62 mmol/L, 14 patients) was associated with hyperparathyroidism (p less than 0.02) and raised 1,25(OH)2D3 (p less than 0.05) but raised 1,25(OH)2D3 was also found in most patients in the normocalcaemic group. Lower 25(OH)D3 concentrations were found in the group with normal 1,25(OH)2D3 compared to the group with elevated 1,25(OH)2D3 (p less than 0.05). Low values of 24,25(OH)2D3 were found in both the normocalcaemic and hypercalcaemic patients (p less than 0.002). Impaired creatinine clearance (less than or equal to 55 ml/min, mean: 38 ml/min) was not associated with reduced 1,25(OH)2D3. No difference in D3 metabolites was found between hypophosphataemic and normophosphataemic patients.
在肾移植后的不同时间点,对26例患者检测了维生素D3代谢产物和甲状旁腺激素(iPTH)。高钙血症(血清钙大于2.62 mmol/L,共14例患者)与甲状旁腺功能亢进相关(p<0.02),且1,25(OH)2D3升高(p<0.05),但在血钙正常组的大多数患者中也发现了1,25(OH)2D3升高。与1,25(OH)2D3升高组相比,1,25(OH)2D3正常组的25(OH)D3浓度更低(p<0.05)。血钙正常和高钙血症患者的24,25(OH)2D3值均较低(p<0.002)。肌酐清除率受损(小于或等于55 ml/min,平均:38 ml/min)与1,25(OH)2D3降低无关。低磷血症和正常磷血症患者的D3代谢产物无差异。